Trials / Completed
CompletedNCT06139341
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated
Safety, Tolerability, and Pharmacokinetics of Single Rising Intravenous Doses of BI 765845 in Healthy Male Japanese Subjects (Single-blind, Randomised, Placebo-controlled, Parallel Group Design)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 765845 in healthy male Japanese subjects following intravenous administration of single rising doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 765845 | BI 765845 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2023-07-21
- Primary completion
- 2023-12-17
- Completion
- 2023-12-17
- First posted
- 2023-11-18
- Last updated
- 2024-01-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06139341. Inclusion in this directory is not an endorsement.